The basis of combining Ritonavir with Lopinavir
**Core Concept**
The combination of Ritonavir with Lopinavir is based on the principle of boosting the pharmacokinetic profile of Lopinavir. Ritonavir is a **protease inhibitor** that inhibits the **cytochrome P450 3A4 (CYP3A4) enzyme**, which is responsible for the metabolism of many drugs, including Lopinavir.
**Why the Correct Answer is Right**
Ritonavir's ability to inhibit CYP3A4 increases the plasma concentrations of Lopinavir, thereby enhancing its **antiviral efficacy**. This combination is commonly used in the treatment of **HIV infection**. The boosted Lopinavir levels allow for a more sustained and effective suppression of the virus.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because it is not related to the mechanism of action of Ritonavir and Lopinavir.
**Option B:** Incorrect as it does not involve the CYP3A4 enzyme.
**Option C:** Incorrect because it is unrelated to the pharmacokinetic interaction between Ritonavir and Lopinavir.
**Option D:** Incorrect as the question is about the basis of combining these two drugs.
**Clinical Pearl / High-Yield Fact**
The Ritonavir-Lopinavir combination is a classic example of **pharmacokinetic boosting**, where one drug (Ritonavir) is used to increase the levels of another drug (Lopinavir) in the body, thereby enhancing its therapeutic effect.
**Correct Answer:** D. Ritonavir inhibits the cytochrome P450 3A4 enzyme, increasing Lopinavir levels.